Home/Filings/4/0000874716-25-000023
4//SEC Filing

FENNELL GEORGE 4

Accession 0000874716-25-000023

CIK 0000874716other

Filed

Feb 17, 7:00 PM ET

Accepted

Feb 18, 9:42 PM ET

Size

25.3 KB

Accession

0000874716-25-000023

Insider Transaction Report

Form 4
Period: 2025-02-13
FENNELL GEORGE
CORPORATE VICE PRESIDENT
Transactions
  • Exercise/Conversion

    Common Stock

    2025-02-14+518,227 total
  • Exercise/Conversion

    Common Stock

    2025-02-14+568,283 total
  • Exercise/Conversion

    Common Stock

    2025-02-14+578,340 total
  • Exercise/Conversion

    Common Stock

    2025-02-14+1408,480 total
  • Tax Payment

    Common Stock

    2025-02-14$444.53/sh133$59,1228,347 total
  • Award

    Non-Qualified Stock Option (right-to-buy)

    2025-02-13+3,4153,415 total
    Exercise: $459.76Exp: 2035-02-12Common Stock (3,415 underlying)
  • Award

    Incentive Stock Option (right-to-buy)

    2025-02-13+217217 total
    Exercise: $459.76Exp: 2035-02-12Common Stock (217 underlying)
  • Award

    Restricted Stock Unit

    2025-02-13+816816 total
    Common Stock (816 underlying)
  • Exercise/Conversion

    Restricted Stock Unit

    2025-02-14510 total
    Common Stock (51 underlying)
  • Exercise/Conversion

    Restricted Stock Unit

    2025-02-145655 total
    Common Stock (56 underlying)
  • Exercise/Conversion

    Restricted Stock Unit

    2025-02-1457112 total
    Common Stock (57 underlying)
  • Exercise/Conversion

    Restricted Stock Unit

    2025-02-14140417 total
    Common Stock (140 underlying)
Footnotes (7)
  • [F1]Grant of option to buy shares of Issuer common stock that becomes exercisable in four annual installments beginning February 14, 2026.
  • [F2]Grant of option to buy shares of Issuer common stock that becomes exercisable in one installment on February 14, 2029.
  • [F3]Each restricted stock unit ('RSU') represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2026.
  • [F4]Each RSU represents a contingent right to receive one share of Issuer. common stock and vested in four annual installments, beginning on February 14, 2022.
  • [F5]Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments, beginning on February 14, 2023.
  • [F6]Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments, beginning on February 14, 2024.
  • [F7]Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments, beginning on February 14, 2025.

Issuer

IDEXX LABORATORIES INC /DE

CIK 0000874716

Entity typeother

Related Parties

1
  • filerCIK 0001521861

Filing Metadata

Form type
4
Filed
Feb 17, 7:00 PM ET
Accepted
Feb 18, 9:42 PM ET
Size
25.3 KB